CEMIPLIMAB-RWLC vs CERITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CEMIPLIMAB-RWLC vs CERITINIB: Safety Overview
| Metric | CEMIPLIMAB-RWLC | CERITINIB |
|---|---|---|
| Total FAERS Reports | 1,554 | 2,796 |
| Deaths Reported | 323 | 786 |
| Death Rate | 20.8% | 28.1% |
| Hospitalizations | 441 | 804 |
| Average Patient Age | 70.2 yrs | 55.6 yrs |
| % Female Patients | 40.6% | 55.1% |
| FDA Approval Date | N/A | Apr 29, 2014 |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Discontinued |